Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?

To: dougle who wrote (134)	12/18/1997 6:50:00 PM
From: MarcG	Read Replies (1) \| Respond to of 857

Thanks Doug for the block count. I noticed the stock was bid for size at the 4 1/4 level through the close. Even though the stock didn't follow through, Linda, it didn't come in either and ended the day 1/8 off the daily high. Some of the big cap names in the group like BMY were hit pretty hard, so I think some more market rotation will be in store. There's so much money in this group, I think some of it has to speculate on Ampligen's applications. Of course, the big ? is the FDA's analysis of the data.